Four-month-old infant with chronic granulomatous disease and invasive aspergillosis with bone involvement

Héctor Gómez-Tello, Estefany Graciela Mamani-Velásquez, Ana Karen Gómez-Gutiérrez, Carlos Sánchez-Flores, Virginia Lora-Téllez, Sara Espinosa-Padilla, Lizbeth Blancas-Galicia, .

Keywords: granulomatous disease, chronic, aspergillosis, invasive pulmonary aspergillosis, NADPH oxidase, infant, primary immunodeficiency diseases

Abstract

Chronic granulomatous disease is the inborn error of immunity with the highest frequency of invasive aspergillosis. In this context, invasive aspergillosis is frequent in adolescence, with rare cases before one year of age. We present a case of chronic granulomatous disease and invasive aspergillosis in a four-month-old infant.
The patient was a male infant living in jail with his hypothyroid mother. He presented with a tumor in the left axillary region when he was four months old, and the chest X-ray suggested rib fractures. The patient was hospitalized on suspicion of child abuse. The chest computed tomography scan showed axillary abscess, rib osteolysis, pneumonia, and pulmonary nodules. He was treated with broad-spectrum antibiotics, and then he was discharged.
Four months later, he was readmitted with fever and extension of the purulent abscess to the left scapular region; a computed tomography scan showed worsening images.
Aspergillus fumigatus was isolated from the abscess pus, leading to an invasive aspergillosis diagnosis. The patient was treated with voriconazole for 28 days, and
then he was discharged. The chronic granulomatous disease was diagnosed by the dihydrorhodamine test. The mutated gene causing the inborn error of immunity was CYBB with the variant c.80_83del/Y; the mother was the carrier (c.80_83del/WT).
At 12 months of age, the patient was readmitted for invasive aspergillosis, refractory to treatment, and died.
This exceptional case teaches us how environmental conditions determine exposure to infectious agents in chronic granulomatous disease patients. Also, it illustrates that invasive aspergillosis can develope in infants with this pathology and should be treated aggressively.

Downloads

Download data is not yet available.
  • Héctor Gómez-Tello Departamento de Alergias, Hospital para el Niño Poblano, Puebla, México https://orcid.org/0000-0003-4849-2131
  • Estefany Graciela Mamani-Velásquez Laboratorio de Inmunodeficiencias, Instituto Nacional de Pediatría, Ciudad de México, México; Departamento de Pediatría, Hospital del Niño “Dr. Ovidio Aliaga Uría”, La Paz, Bolivia https://orcid.org/0000-0001-7122-9134
  • Ana Karen Gómez-Gutiérrez Laboratorio de Inmunodeficiencias, Instituto Nacional de Pediatría, Ciudad de México, México
  • Carlos Sánchez-Flores Laboratorio de Inmunodeficiencias, Instituto Nacional de Pediatría, Ciudad de México, México https://orcid.org/0009-0007-6263-442X
  • Virginia Lora-Téllez Laboratorio de Micobacteriosis y Micología Médica, Hospital para el Niño Poblano, Puebla, México
  • Sara Espinosa-Padilla Laboratorio de Inmunodeficiencias, Instituto Nacional de Pediatría, Ciudad de México, México https://orcid.org/0000-0003-4859-3151
  • Lizbeth Blancas-Galicia Laboratorio de Inmunodeficiencias, Instituto Nacional de Pediatría, Ciudad de México, México https://orcid.org/0000-0002-3861-8864

References

Antachopoulos C, Walsh TJ, Roilides E. Fungal infections in primary immunodeficiencies. Eur J Pediatr. 2007;166:1099-117. https://doi.org/10.1007/s00431-007-0527-7

Zaoutis TE, Heydon K, Chu JH, Walsh TJ, Steinbach WJ. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics. 2006;117:e711-6. https://doi.org/10.1542/peds.2005-1161

Henriet S, Verweij PE, Holland SM, Warris A. Invasive fungal infections in patients with chronic granulomatous disease. Adv Exp Med Biol. 2013:764:27-55. http://doi.org/10.1007/978-1-4614-4726-9_3

King J, Henriet S, Warris A. Aspergillosis in chronic granulomatous disease. J Fungi (Basel). 2016;2:15. https://doi.org/10.3390/jof2020015

Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60:1176-83. https://doi.org/10.1093/cid/ciu1154

Saito S, Oda A, Kasai M, Minami K, Nagumo H, Shiohara M, et al. A neonatal case of chronic granulomatous disease, initially presented with invasive pulmonary aspergillosis. J Infect Chemother. 2014;20:220-3. http://doi.org/10.1016/j.jiac.2013.10.008

Yoo YJ, Sun JS, Lee JH, Jung HJ, Koh YH, Jung J, et al. Atypical presentation of chronic granulomatous disease in a neonate with a pulmonary granuloma mimicking a tumor: A case report. J Korean Soc Radiol. 2020;81:990. http://doi.org/10.3348/jksr.2020.81.4.990

Herman TE, Siegel MJ. Chronic granulomatous disease of childhood: Neonatal Serratia, hepatic abscesses, and pulmonary aspergillosis. J Perinatol. 2002;22:255-6. http://doi.org/10.1038/sj.jp.7210708

Lee BW, Yap HK. Polyarthritis resembling juvenile rheumatoid arthritis in a girl with chronic granulomatous disease. Arthritis Rheum. 1994;37:773-6. http://doi.org/10.1002/art.1780370524

Davoodi P, Wright SA, Brown EV, Perry JR. Rare diagnosis in a neonate who presents with fever. Clin Pediatr (Phila). 2015;54:91-3. http://doi.org/10.1177/0009922814541809

Chang JH, Boxer LA. Case 2: Infant with lung nodules. Paediatr Child Health. 2007;12:313-6. http://doi.org/10.1093/pch/12.4.229

Mouy R, Ropert JC, Donadieu J, Hubert P, de Blic J, Revillon Y, et al. Granulomatose septique chronique révélée par une aspergillose pulmonaire néonatale. Arch Pediatr. 1995;2:861-4. http://doi.org/10.1016/0929-693x(96)81264-4

Guo C, Chen X, Wang J, Liu F, Liang Y, Yang J, et al. Clinical manifestations and genetic analysis of 4 children with chronic granulomatous disease. Medicine (Baltimore). 2020;99:1-7. http://doi.org/10.1097/md.0000000000020599

Theobald I, Fischbach R, Hülskamp G, Franzius C, Frosch M, Roth J, et al. Pulmonale aspergillose als erstmanifestation einer septischen granulomatose (chronic granulomatous disease, CGD) bei eineiigen weiblichen zwillingsfrühgeborenen und ausbreitungsdiagnostik mittels FDG-PET. Radiologe. 2002;42:42-5. https://doi.org/10.1007/s117-002-8116-0

Lamberto Y, Domínguez C, Arechavala A, Saúl P, Chediack V, Cunto E. Aspergilosis invasiva: definiciones, diagnóstico y tratamiento. Medicina (B Aires). 2023;83:82-95.

Bukkems LMP, van Dommelen L, Regis M, van den Heuvel E, Nieuwenhuizen L. The use of galactomannan antigen assays for the diagnosis of invasive pulmonary aspergillosis in the hematological patient: A systematic review and meta-analysis. J Fungi (Basel). 2023;9:674. https://doi.org/10.3390/jof9060674

Yeoh DK, McMullan BJ, Clark JE, Slavin MA, Haeusler GM, Blyth CC. The challenge of diagnosing invasive pulmonary aspergillosis in children: A review of existing and emerging tools. Mycopathologia. 2023;188:731-43. https://doi.org/10.1007/s11046-023-00714-4

Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e1-60. https://doi.org/10.1093/cid/ciw326

Douglas AP, Smibert OliviaC, Bajel A, Halliday CL, Lavee O, McMullan B, et al. Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021. Intern Med J. 2021;51:143-76. https://doi.org/10.1111/imj.15591

Abo YN, Gwee A, Osowicki J. Rare infant case of pulmonary aspergilloma highlighting common challenges with voriconazole dosing. Pediatr Infect Dis J. 2021;40:227-30. https://doi.org/10.1097/INF.0000000000002959

Kuruvilla M, de la Morena MT. Antibiotic prophylaxis in primary immune deficiency disorders. J Allergy Clin Immunol Pract. 2013;1:573-82. http://doi.org/10.1016/j.jaip.2013.09.013

How to Cite
1.
Gómez-Tello H, Mamani-Velásquez EG, Gómez-Gutiérrez AK, Sánchez-Flores C, Lora-Téllez V, Espinosa-Padilla S, et al. Four-month-old infant with chronic granulomatous disease and invasive aspergillosis with bone involvement. Biomed. [Internet]. 2024 Dec. 23 [cited 2025 Apr. 3];44(Sp. 2):31-8. Available from: https://revistabiomedicaorg.biteca.online/index.php/biomedica/article/view/7537

Some similar items:

Published
2024-12-23

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo
QR Code